Mann Devin M, Allegrante John P, Natarajan Sundar, Halm Ethan A, Charlson Mary
Division of General Internal Medicine, Mount Sinai School of Medicine, 1470 Madison Ave, Box 1087, New York, NY 10029, USA.
Cardiovasc Drugs Ther. 2007 Aug;21(4):311-6. doi: 10.1007/s10557-007-6040-4.
Statins are potent drugs for reducing cholesterol and cardiovascular disease; however, their effectiveness is significantly compromised by poor adherence. This prospective study was designed to identify potentially modifiable patient factors including medication, disease, and diet beliefs related to statin adherence.
Veterans (n = 71) given their first prescription of a statin for primary prevention were interviewed at baseline, 3 months, and 6 months regarding medication, disease, and diet beliefs along with self-reported statin adherence.
At 6-month follow-up, 55% of the cohort was non-adherent with 10% reporting never having started their statin, 50% reporting misconceptions about the duration of treatment and a median use of <2 months among those who discontinued their statin. Multivariate predictors of non-adherence were expected short treatment duration (OR = 3.6, 1.4-9.4), low perceived risk of myocardial infarction (OR = 3.1, 1.1-8.7), concern about potential harm from statins (OR = 2.5, 1.0-6.3), being Hispanic (OR = 3.9, 1.0-15.2), and younger age (OR = 4.2, 1.1-15.8).
Poor adherence to statins was common in this primary prevention population with frequent early discontinuation despite access to low-cost medicines. Patient factors regarding the perception of risk, toxic effects of medication, expected treatment duration, as well as socio-demographic factors, were significant predictors of poor adherence and warrant further exploration.
他汀类药物是降低胆固醇和心血管疾病的有效药物;然而,其疗效因依从性差而大打折扣。本前瞻性研究旨在确定与他汀类药物依从性相关的潜在可改变的患者因素,包括用药、疾病和饮食观念。
对71名首次接受他汀类药物一级预防处方的退伍军人在基线、3个月和6个月时就用药、疾病和饮食观念以及自我报告的他汀类药物依从性进行访谈。
在6个月的随访中,55%的队列未坚持用药,10%报告从未开始服用他汀类药物,50%报告对治疗持续时间存在误解,在停用他汀类药物的患者中,中位用药时间<2个月。不依从的多变量预测因素包括预期治疗时间短(比值比=3.6,1.4 - 9.4)、心肌梗死感知风险低(比值比=3.1,1.1 - 8.7)、对他汀类药物潜在危害的担忧(比值比=2.5,1.0 - 6.3)、西班牙裔(比值比=3.9,1.0 - 15.2)和年龄较小(比值比=4.2,1.1 - 15.8)。
在这个一级预防人群中,尽管可以获得低成本药物,但他汀类药物依从性差很常见,且早期停药频繁。患者对风险的认知、药物毒性作用、预期治疗时间等因素以及社会人口统计学因素是依从性差的重要预测因素,值得进一步探索。